91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global mRNA Platform Market Insights, Forecast to 2029

Global mRNA Platform Market Insights, Forecast to 2029

Publication ID: 
PB504232314
Publication Date: 
June 6, 2023
Pages: 
93
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 4,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Healthcare [2]
Pharma & Healthcare [3]
Description: 

Market Analysis and Insights: Global mRNA Platform Market
The global mRNA Platform market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for mRNA Platform is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of mRNA Platform include Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for mRNA Platform market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of mRNA Platform, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for mRNA Platform, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Platform revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global mRNA Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for mRNA Platform revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Arcturus Therapeutic, Argos Therapeutics, BioNTec, CureVac, Etherna, Ethris, GlaxoSmithKline, Pfizer and Translate Bio, etc.
By Company
Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio
Segment by Type
Infectious Disease Vaccines
Cancer Vaccines
Segment by Application
Infectious Disease
Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of mRNA Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Platform companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Platform revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Platform Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Platform Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Platform Market Perspective (2018-2029)
2.2 Global mRNA Platform Growth Trends by Region
2.2.1 mRNA Platform Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Platform Historic Market Size by Region (2018-2023)
2.2.3 mRNA Platform Forecasted Market Size by Region (2024-2029)
2.3 mRNA Platform Market Dynamics
2.3.1 mRNA Platform Industry Trends
2.3.2 mRNA Platform Market Drivers
2.3.3 mRNA Platform Market Challenges
2.3.4 mRNA Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue mRNA Platform by Players
3.1.1 Global mRNA Platform Revenue by Players (2018-2023)
3.1.2 Global mRNA Platform Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of mRNA Platform, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global mRNA Platform Market Concentration Ratio
3.4.1 Global mRNA Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Platform Revenue in 2022
3.5 Global Key Players of mRNA Platform Head office and Area Served
3.6 Global Key Players of mRNA Platform, Product and Application
3.7 Global Key Players of mRNA Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Platform Breakdown Data by Type
4.1 Global mRNA Platform Historic Market Size by Type (2018-2023)
4.2 Global mRNA Platform Forecasted Market Size by Type (2024-2029)
5 mRNA Platform Breakdown Data by Application
5.1 Global mRNA Platform Historic Market Size by Application (2018-2023)
5.2 Global mRNA Platform Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America mRNA Platform Market Size (2018-2029)
6.2 North America mRNA Platform Market Size by Type
6.2.1 North America mRNA Platform Market Size by Type (2018-2023)
6.2.2 North America mRNA Platform Market Size by Type (2024-2029)
6.2.3 North America mRNA Platform Market Share by Type (2018-2029)
6.3 North America mRNA Platform Market Size by Application
6.3.1 North America mRNA Platform Market Size by Application (2018-2023)
6.3.2 North America mRNA Platform Market Size by Application (2024-2029)
6.3.3 North America mRNA Platform Market Share by Application (2018-2029)
6.4 North America mRNA Platform Market Size by Country
6.4.1 North America mRNA Platform Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America mRNA Platform Market Size by Country (2018-2023)
6.4.3 North America mRNA Platform Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe mRNA Platform Market Size (2018-2029)
7.2 Europe mRNA Platform Market Size by Type
7.2.1 Europe mRNA Platform Market Size by Type (2018-2023)
7.2.2 Europe mRNA Platform Market Size by Type (2024-2029)
7.2.3 Europe mRNA Platform Market Share by Type (2018-2029)
7.3 Europe mRNA Platform Market Size by Application
7.3.1 Europe mRNA Platform Market Size by Application (2018-2023)
7.3.2 Europe mRNA Platform Market Size by Application (2024-2029)
7.3.3 Europe mRNA Platform Market Share by Application (2018-2029)
7.4 Europe mRNA Platform Market Size by Country
7.4.1 Europe mRNA Platform Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe mRNA Platform Market Size by Country (2018-2023)
7.4.3 Europe mRNA Platform Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China mRNA Platform Market Size (2018-2029)
8.2 China mRNA Platform Market Size by Type
8.2.1 China mRNA Platform Market Size by Type (2018-2023)
8.2.2 China mRNA Platform Market Size by Type (2024-2029)
8.2.3 China mRNA Platform Market Share by Type (2018-2029)
8.3 China mRNA Platform Market Size by Application
8.3.1 China mRNA Platform Market Size by Application (2018-2023)
8.3.2 China mRNA Platform Market Size by Application (2024-2029)
8.3.3 China mRNA Platform Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia mRNA Platform Market Size (2018-2029)
9.2 Asia mRNA Platform Market Size by Type
9.2.1 Asia mRNA Platform Market Size by Type (2018-2023)
9.2.2 Asia mRNA Platform Market Size by Type (2024-2029)
9.2.3 Asia mRNA Platform Market Share by Type (2018-2029)
9.3 Asia mRNA Platform Market Size by Application
9.3.1 Asia mRNA Platform Market Size by Application (2018-2023)
9.3.2 Asia mRNA Platform Market Size by Application (2024-2029)
9.3.3 Asia mRNA Platform Market Share by Application (2018-2029)
9.4 Asia mRNA Platform Market Size by Region
9.4.1 Asia mRNA Platform Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia mRNA Platform Market Size by Region (2018-2023)
9.4.3 Asia mRNA Platform Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America mRNA Platform Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America mRNA Platform Market Size by Type
10.2.1 Middle East, Africa, and Latin America mRNA Platform Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America mRNA Platform Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America mRNA Platform Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America mRNA Platform Market Size by Application
10.3.1 Middle East, Africa, and Latin America mRNA Platform Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America mRNA Platform Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America mRNA Platform Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America mRNA Platform Market Size by Country
10.4.1 Middle East, Africa, and Latin America mRNA Platform Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America mRNA Platform Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America mRNA Platform Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Arcturus Therapeutic
11.1.1 Arcturus Therapeutic Company Details
11.1.2 Arcturus Therapeutic Business Overview
11.1.3 Arcturus Therapeutic mRNA Platform Introduction
11.1.4 Arcturus Therapeutic Revenue in mRNA Platform Business (2018-2023)
11.1.5 Arcturus Therapeutic Recent Developments
11.2 Argos Therapeutics
11.2.1 Argos Therapeutics Company Details
11.2.2 Argos Therapeutics Business Overview
11.2.3 Argos Therapeutics mRNA Platform Introduction
11.2.4 Argos Therapeutics Revenue in mRNA Platform Business (2018-2023)
11.2.5 Argos Therapeutics Recent Developments
11.3 BioNTec
11.3.1 BioNTec Company Details
11.3.2 BioNTec Business Overview
11.3.3 BioNTec mRNA Platform Introduction
11.3.4 BioNTec Revenue in mRNA Platform Business (2018-2023)
11.3.5 BioNTec Recent Developments
11.4 CureVac
11.4.1 CureVac Company Details
11.4.2 CureVac Business Overview
11.4.3 CureVac mRNA Platform Introduction
11.4.4 CureVac Revenue in mRNA Platform Business (2018-2023)
11.4.5 CureVac Recent Developments
11.5 Etherna
11.5.1 Etherna Company Details
11.5.2 Etherna Business Overview
11.5.3 Etherna mRNA Platform Introduction
11.5.4 Etherna Revenue in mRNA Platform Business (2018-2023)
11.5.5 Etherna Recent Developments
11.6 Ethris
11.6.1 Ethris Company Details
11.6.2 Ethris Business Overview
11.6.3 Ethris mRNA Platform Introduction
11.6.4 Ethris Revenue in mRNA Platform Business (2018-2023)
11.6.5 Ethris Recent Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline mRNA Platform Introduction
11.7.4 GlaxoSmithKline Revenue in mRNA Platform Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer mRNA Platform Introduction
11.8.4 Pfizer Revenue in mRNA Platform Business (2018-2023)
11.8.5 Pfizer Recent Developments
11.9 Translate Bio
11.9.1 Translate Bio Company Details
11.9.2 Translate Bio Business Overview
11.9.3 Translate Bio mRNA Platform Introduction
11.9.4 Translate Bio Revenue in mRNA Platform Business (2018-2023)
11.9.5 Translate Bio Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned: 

Arcturus Therapeutic
Argos Therapeutics
BioNTec
CureVac
Etherna
Ethris
GlaxoSmithKline
Pfizer
Translate Bio

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-mrna-platform-market-insights-forecast-2029

Links
[1] /countries/global[2] /healthcare[3] /pharma-healthcare